About the Authors
- Sarah Hanieh
-
* E-mail: haniehs@student.unimelb.edu.au
Affiliations Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom, Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Mainga Hamaluba
-
Affiliations Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom, Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Dominic F. Kelly
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Jane A. Metz
-
Affiliations Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom, Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Kelly L. Wyres
-
Affiliation Department of Zoology, University of Oxford, Oxford, United Kingdom
- Roberta Fisher
-
Affiliation Department of Zoology, University of Oxford, Oxford, United Kingdom
- Rahul Pradhan
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Disuja Shakya
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Lochan Shrestha
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Amrita Shrestha
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Anip Joshi
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Jocelyn Habens
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Bishnu D. Maharjan
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Stephen Thorson
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- Erik Bohler
-
Affiliation Okhaldhunga Community Hospital, Okhaldhunga, Nepal
- Ly-Mee Yu
-
Affiliation Nuffield Department of Primary Care and Health Sciences, University of Oxford, Oxford, United Kingdom
- Sarah Kelly
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Emma Plested
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Tessa John
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
- Anja M. Werno
-
Affiliations Department of Pathology, University of Otago, Christchurch, New Zealand, Canterbury Health Laboratories, Christchurch, New Zealand
- Neelam Adhikari
-
Affiliation Patan Academy Paediatric Research Unit, Patan Academy of Health Sciences, Kathmandu, Nepal
- David R. Murdoch
-
Affiliations Department of Pathology, University of Otago, Christchurch, New Zealand, Canterbury Health Laboratories, Christchurch, New Zealand
- Angela B. Brueggemann
-
Affiliation Department of Zoology, University of Oxford, Oxford, United Kingdom
- Andrew J. Pollard
-
Affiliation Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
Competing Interests
AJP conducts clinical trials on behalf of the University of Oxford that are sponsored by manufacturers of pneumococcal conjugate vaccines but does not receive any personal payments from them. The University of Oxford receives unrestricted educational grants for courses and conferences organised by AJP from vaccine manufacturers. DFK has received support to attend scientific meetings from GlaxoSmithKline Biologicals SA and Pfizer and holds research funding through the University of Oxford from GlaxoSmithKline Biologicals SA. We declare that authors AW and DRM are employed by Canterbury Health Laboratories. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: SH DFK ST LY SK AB AJP. Performed the experiments: SH MH JM KW RF RP DS LS AS AJ JH BM AW AB. Analyzed the data: SH MH DFK LY. Contributed reagents/materials/analysis tools: ST EB EP TJ AW NA DRM ABB AJP. Wrote the paper: SH MH DFK JM AB AJP.